Hutchin Hill Capital’s Halozyme HALO Stock Holding History

Hutchin Hill Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-60,000	Closed	-$477K	–	514
2013 Q2	$477K	Buy	+60,000	New	+$382K	0.05%	302

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Hutchin Hill Capital's HALO Position: Q3 2013 in Review

Hutchin Hill Capital sold out of Halozyme (HALO) in Q3 2013, closing a stake of 60,000 shares — an estimated $477K sold.

Hutchin Hill Capital first reported a position in HALO in Q2 2013 and held it in 1 quarter. The position peaked at $477K in Q2 2013. 110 funds tracked by Wall St. Rank hold HALO as of Q3 2013.

Hutchin Hill Capital reported no remaining Halozyme position as of Q3 2013 after selling out during the quarter.
Hutchin Hill Capital sold 60,000 Halozyme shares in Q3 2013, an estimated $477K.
Hutchin Hill Capital first reported a position in Halozyme in Q2 2013 and held it in 1 quarter.
Hutchin Hill Capital's Halozyme position peaked at $477K in Q2 2013.
110 funds tracked by Wall St. Rank held Halozyme as of Q3 2013.

Based on Hutchin Hill Capital's 13F filing for Q3 2013, filed 14 Nov 2013.